Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2023 | Accessibility of CAR-T and the move from specialist centers

Charalambos Andreadis, MD, MSCE, UCSF Health, San Francisco, CA, briefly discusses the accessibility challenges faced with CAR T-cell therapy, as this treatment option is only available in specialist centers. Dr Andreadis hopes that with advances in the field, CAR-T will become accessible to a greater proportion of patients. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Consultancy: Kite/Gilead, BMS, Novartis; Grants or contracts: BMS, Novartis, Genentech; Research Funding: Merck & Co., Inc.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.